Renaissance Capital logo

EYEN News

Think micro: Eye biotech Eyenovia prices $27 million IPO at $10 low end

Eyenovia logo

Eyenovia, which is developing micro-formulations of common eye therapies, raised $27 million by offering 2.7 million shares at $10, the low end of the range of $10 to $12. Eyenovia plans to list on the Nasdaq under the symbol EYEN. Ladenburg Thalmann and Roth...read more

US IPO Week Ahead: 10 IPOs expected to price, led by PagSeguro's $1.8 billion deal

ENTX

Ten deals are expected to price next week, raising a combined $3.1 billion in proceeds, as this month gears up to be the busiest January in over eight years in terms of proceeds raised ($3.1 billion raised to date). The week will be headlined by the "Paypal...read more

Glaucoma therapy developer Eyenovia sets terms for $30 million IPO

Eyenovia logo

Eyenovia, which is developing micro-formulations of common eye therapies, announced terms for its IPO on Tuesday. The New York, NY-based company plans to raise $30 million by offering 2.7 million shares at a price range of $10 to $12. Insiders intend to...read more

US IPO Weekly Recap: 2 Chinese deals cap off 2017

LX

Two Chinese companies raised a combined $138 million to close out 2017 with an even 160 IPOs. The deals included online lender LexinFintech Holdings and adtech firm iClick Interactive. Given the recent sell-off of US-listed...read more